Catalyst Pharmaceuticals, Inc. (CPRX)

Jul 15, 2026 - CPRX was delisted (reason: acquired by Angelini Pharma)

31.49

0.00 (0.00%)

Inactive · Last trade price on Jul 15, 2026

Catalyst Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	596.96	588.99	491.73	398.2	214.2	140.83
Revenue Growth	11.65%	19.78%	23.49%	85.90%	52.10%	18.27%
Gross Profit	513.14	501.74	422.89	346.24	179.81	118.95
Operating Income	267.64	257.78	195.12	86.81	101.84	52.39
Net Income	221.32	214.33	163.89	71.41	83.08	39.48
Earnings Per Share	1.74	1.68	1.31	0.63	0.75	0.37
EPS Growth	10.83%	28.24%	107.94%	-16.00%	102.70%	-47.89%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	755.86	709.17	517.55	137.64	298.4	191.27
Total Debt	2.24	2.35	2.79	3.19	3.56	3.89
Net Cash (Debt)	753.62	706.82	514.77	134.45	294.84	187.37
Net Cash Growth	30.39%	37.31%	282.87%	-54.40%	57.35%	33.57%
Net Cash Per Share	5.92	5.55	4.12	1.18	2.65	1.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	208.21	208.67	239.81	143.6	116.05	60.37
Capital Expenditures	-0.09	-0.06	-0.56	-0.23	-0.03	-1.02
Free Cash Flow	208.13	208.61	239.25	143.37	116.02	59.35
Free Cash Flow Growth	-22.21%	-12.81%	66.88%	23.57%	95.48%	31.82%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	85.96%	85.19%	86.00%	86.95%	83.94%	84.46%
Operating Margin	44.83%	43.77%	39.68%	21.80%	47.54%	37.20%
Pretax Margin	49.66%	48.14%	43.98%	23.73%	48.89%	37.40%
Profit Margin	37.08%	36.39%	33.33%	17.93%	38.79%	28.03%
FCF Margin	34.86%	35.42%	48.65%	36.00%	54.16%	42.14%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	18.20	13.89	15.93	26.68	24.80	18.30
Forward PE	15.69	15.48	15.38	14.13	14.98	13.97
P/FCF Ratio	18.52	13.71	10.54	12.56	16.88	11.75
PS Ratio	6.46	4.85	5.13	4.52	9.14	4.95